Aclaris Therapeutics, Inc. (LON:0H8T)
London · Delayed Price · Currency is GBP · Price in USD 2.495
-0.040 (-1.58%)
At close: Nov 3, 2025
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of 210.97 million as of November 4, 2025. Its market cap has increased by 228.79% in one year.
Market Cap
210.97M
Enterprise Value
75.16M
Revenue
12.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.50
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from 140.05M to 210.97M, an increase of 50.64%. That is a compound annual growth rate of 4.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 210.97M | -0.49% |
| Dec 31, 2024 | 212.00M | 263.06% |
| Dec 29, 2023 | 58.39M | -93.30% |
| Dec 30, 2022 | 871.66M | 32.58% |
| Dec 31, 2021 | 657.46M | 223.25% |
| Dec 31, 2020 | 203.39M | 244.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.57B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |